Generics Firms On Standby With Tecfidera Appeal Due ‘At Any Time’

Implication Of Potential Pro-Biogen Ruling Unclear

 
• By Dean Rudge
Biogen_Switzerland
first-quarter 2021 sales of Tecfidera nosedived by 79% • Source: Shutterstock

More from Generics

More from Products